These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38879503)

  • 41. Predictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy: A Prisma-Compliant Meta-Analysis.
    Qixing M; Gaochao D; Wenjie X; Rong Y; Feng J; Lin X; Mantang Q; Qiang C
    Medicine (Baltimore); 2015 Sep; 94(39):e1593. PubMed ID: 26426637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive Value of Two Polymorphisms of ERCC2, rs13181 and rs1799793, in Clinical Outcomes of Chemotherapy in Gastric Cancer Patients: A Meta-Analysis.
    Li M; Zhao Y; Zhao E; Wang K; Lu W; Yuan L
    Dis Markers; 2018; 2018():3947626. PubMed ID: 30581498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Comprehensive Analysis of Influence ERCC Polymorphisms Confer on the Development of Brain Tumors.
    Geng P; Ou J; Li J; Liao Y; Wang N; Xie G; Sa R; Liu C; Xiang L; Liang H
    Mol Neurobiol; 2016 May; 53(4):2705-14. PubMed ID: 26264164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of genetic polymorphisms in DNA repair genes
    Alsagaby S; Ahmed AA; Rasheed Z; Althwab SA; Aljohani ASM; Alhumaydhi FA; Alhomaidan HT; Alkhamiss AS; Alkhowailed M; Alaqeel A; Alblihed MA; Alrehaili J; Fernández N; Abdulmonem WA
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(5-6):530-554. PubMed ID: 35319340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies.
    Ding DP; Ma WL; He XF; Zhang Y
    Mol Biol Rep; 2012 Mar; 39(3):2533-40. PubMed ID: 21667112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: a meta-analysis.
    Zhu H; Cao S; Liu Y; Ding X; Wu Q; Ma H
    J Cancer Res Ther; 2013; 9(2):187-92. PubMed ID: 23771356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymorphisms in XPD and hOGG1 and prostate cancer risk: a meta-analysis.
    Zhu S; Zhang H; Tang Y; Wang J
    Urol Int; 2012; 89(2):233-40. PubMed ID: 22890093
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: a meta-analysis.
    Duan XL; Gong H; Zeng XT; Ni XB; Yan Y; Chen W; Liu GL
    Asian Pac J Cancer Prev; 2012; 13(7):3299-303. PubMed ID: 22994751
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contribution of DNA Repair Xeroderma Pigmentosum Group D Genotype to Gastric Cancer Risk in Taiwan.
    Ji HX; Chang WS; Tsai CW; Wang JY; Huang NK; Lee AS; Shen MY; Chen WY; Chiang YC; Shih TC; Hsu CM; Bau DT
    Anticancer Res; 2015 Sep; 35(9):4975-81. PubMed ID: 26254397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk Modulation of Oral Pre Cancer and Cancer with Polymorphisms in XPD and XPG Genes in North Indian Population.
    Nigam K; Yadav SK; Samadi FM; Bhatt ML; Gupta S; Sanyal S
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2397-2403. PubMed ID: 31450912
    [TBL] [Abstract][Full Text] [Related]  

  • 51. XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies.
    Yin QH; Liu C; Hu JB; Meng RR; Li L; Wang YJ
    Asian Pac J Cancer Prev; 2013; 14(1):231-6. PubMed ID: 23534729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contribution of xeroderma pigmentosum complementation group D gene polymorphisms in breast and ovarian cancer susceptibility: A protocol for systematic review and meta analysis.
    Tian Y; Lin X; Yang F; Zhao J; Yao K; Bian C
    Medicine (Baltimore); 2020 May; 99(21):e20299. PubMed ID: 32481313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comprehensive assessment of associations between ERCC2 Lys751Gln/Asp312Asn polymorphisms and risk of non- Hodgkin lymphoma.
    Zhou JY; He LW; Liu J; Yu HL; Wei M; Ma WL; Shi R
    Asian Pac J Cancer Prev; 2014; 15(21):9347-53. PubMed ID: 25422223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population.
    Paszkowska-Szczur K; Scott RJ; Górski B; Cybulski C; Kurzawski G; Dymerska D; Gupta S; van de Wetering T; Masojć B; Kashyap A; Gapska P; Gromowski T; Kładny J; Lubiński J; Dębniak T
    Mol Biol Rep; 2015 Mar; 42(3):755-64. PubMed ID: 25391773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Meta-analysis on the association of nucleotide excision repair gene XPD A751C variant and cancer susceptibility among Indian population.
    Mandal RK; Yadav SS; Panda AK
    Mol Biol Rep; 2014 Feb; 41(2):713-9. PubMed ID: 24362511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy.
    Liu R; Zhao X; Liu X; Chen Z; Qiu L; Geng R; Guo W; He G; Yin J; Li J; Zhu X
    Tumour Biol; 2016 Feb; 37(2):1753-62. PubMed ID: 26314858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Associations between XPD Asp312Asn polymorphism and risk of head and neck cancer: a meta-analysis based on 7,122 subjects.
    Hu YY; Yuan H; Jiang GB; Chen N; Wen L; Leng WD; Zeng XT; Niu YM
    PLoS One; 2012; 7(4):e35220. PubMed ID: 22536360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis.
    Yuan H; Niu YM; Wang RX; Li HZ; Chen N
    Genet Mol Res; 2011 Nov; 10(4):3356-64. PubMed ID: 22179996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictive value of XPD polymorphisms on platinum-based chemotherapy in non-small cell lung cancer: a systematic review and meta-analysis.
    Qiu M; Yang X; Hu J; Ding X; Jiang F; Yin R; Xu L
    PLoS One; 2013; 8(8):e72251. PubMed ID: 23977265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Associations between XPD polymorphisms and risk of breast cancer: a meta-analysis.
    Jiang Z; Li C; Xu Y; Cai S; Wang X
    Breast Cancer Res Treat; 2010 Aug; 123(1):203-12. PubMed ID: 20111903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.